GP Nord, located in North-East Europe, the significant advantage is a hands-on attitude to complex issues of sourcing high-quality medicinal products from validated sources throughout the EU. It allows us to supply the demanding markets of Asia, Central America, the Caribbean, EEC, the Middle East, and central Europe.
Because we operate in a wholly validated and professional supply chain, we provide the necessary confidence and assurances to both our customers and suppliers supported by certified documentation and declarations. GP Nord SIA is a pharmaceutical company formed by three childhood friends, former English Latvians in England. Initially, it followed British companies’ example, where the primary business model is the wholesale of European goods to North Africa, the Middle East, China, Central America, and the Caribbean.
Company Details
- Employees
- 14
- Founded
- -
- Address
- Kurzemes Prospekts 23, Riga,riga 1067,latvia
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.gpnord.com
- Keywords
- in Latvia.
- HQ
- Riga, Riga
Gp Nord Sia Questions
Gp Nord Sia's website is http://www.gpnord.com
Gp Nord Sia's LinkedIn profile is https://lv.linkedin.com/company/gpnord
Gp Nord Sia has
14 employees.
View email and phone details for 14
employees at Gp Nord Sia.
Gp Nord Sia's industry is
Pharmaceutical Manufacturing
Gp Nord Sia's top competitors are
Orange Pharma,
Salus International Sp. Z O.o.,
As Recipe Plus,
Medisale Bv,
Medcor Pharmaceuticals,
Pharma Gerke,
Phatebo Gmbh,
Medizone Germany,
Chytrá Lékárna,
Olikla.
Gp Nord Sia's categories are Pharmaceutical Manufacturing
Gp Nord Sia's founding year is 2018
